Aymen Idris

Aymen Idris

University of Sheffield - Sheffield / United Kingdom
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 1035830
Sheffield University
person_outline Aymen Idris's MOST POPULAR ARTICLES
1-) Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptorsAI Idris, RJ van\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'t Hof, IR Greig, SA Ridge, D Baker, RA Ross, SH RalstonNature medicine 11 (7), 774-779, 20054222005
2-) Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitroAI Idris, J Rojas, IR Greig, RJ van’t Hof, SH RalstonCalcified tissue international 82 (3), 191-201, 20082572008
3-) Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cellsAI Idris, A Sophocleous, E Landao-Bassonga, M Canals, G Milligan, ...Cell Metabolism 10 (2), 139-147, 20091762009
4-) Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptorAI Idris, A Sophocleous, E Landao-Bassonga, RJ Van\'t Hof, SH RalstonEndocrinology 149 (11), 5619-5626, 20081772008
5-) The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivoAI Idris, E Landao-Bassonga, SH RalstonBone 46 (4), 1089-1099, 20101322010